PINEAPPLE EXPRESS CANNABIS Co (PNXP) EBITDA (2018 - 2025)

Pineapple Express Cannabis has disclosed EBITDA across 8 years of filings, most recently posting $110947.0 for Q4 2025.

• In Q4 2025, EBITDA rose 8989.98% year-over-year to $110947.0; the TTM figure through Oct 2025 stood at -$336255.0 (down 3635.75% YoY), while the FY2025 annual figure was -$16857.0, up 71.67% from the prior year.
• EBITDA came in at $110947.0 for Q4 2025 at Pineapple Express Cannabis, up from -$246323.0 in the prior quarter.
• In the past five years, EBITDA ranged from a high of $110947.0 in Q4 2025 to a low of -$246323.0 in Q3 2025.
• Average EBITDA over 5 years is -$21296.6, with a median of -$3692.5 recorded in 2022.
• The largest YoY upside for EBITDA was 8989.98% in 2025 against a maximum downside of 5839.12% in 2025.
• Over 5 years, EBITDA stood at $1027.0 in 2021, then tumbled by 466.99% to -$3769.0 in 2022, then soared by 43.88% to -$2115.0 in 2023, then jumped by 40.99% to -$1248.0 in 2024, then jumped by 8989.98% to $110947.0 in 2025.
• Per Business Quant data, the three most recent EBITDA figures were $110947.0 in Q4 2025, -$246323.0 in Q3 2025, and -$184594.0 in Q2 2025.